Background: In recent years, liver transplantation (LT) has become a well-accepted therapeutic modality for children with end-stage liver disease, with transplantation surgery being performed at a younger age. Human herpes virus 6 (HHV-6) infection occurs in most children within the first 2 years of life, therefore, data on primary HHV-6 infection in pediatric liver transplant recipients is scarce.
| INTRODUC TI ON
Human herpes virus 6 (HHV-6), types A and B, are members of the herpesviridae family, belonging to the Betaherpesvirinae subgroup, which also includes human cytomegalovirus (CMV) and human herpes virus 7.
1,2 HHV-6 infects >90% of children within the first 2 years of life, 3, 4 mainly causing roseola infantum, a childhood disease characterized by high-grade fever, mild skin rash, and occasionally complicated by seizures or encephalitis. Primary infection usually occurs at 6 months to 1 year. 1, 2 As with any other herpesviridae family, infections with either type of HHV-6 can persist in the host after the primary infection either in a latent or low level chronic replication state. 1,2 HHV-6 infects T cells.
Latency is achieved by integration into host telomeres, presumably in macrophages/monocytes. 5 Clinical disease because of reactivation in immune deficient children has been well-described, especially in bone marrow transplantation recipients.
1,2
In recent years, LT has become a well-accepted therapeutic modality for children with end-stage liver disease. 6, 7 Children post-solid organ transplantation, require long-term treatment with immunosuppressive drugs and are often exposed to infections. 6 Whereas a primary, as well as a non-primary infection with other types of infections from the herpesviridae family, have been well-described.
Studies reporting on a primary infection with HHV-6, post-pediatric LT are scarce. [8] [9] [10] [11] [12] Most of the previous investigations have dealt with HHV-6 post-LT in general (primary and non-primary), but none have focused on children with only a primary infection. The aim of our study was to describe the course of a primary HHV-6 infection post-pediatric LT.
| ME THODS
This retrospective study was conducted at the Schneider Children's 
| Post-transplant management and treatment
During the study period, transplanted children were usually hospitalized for 3-4 weeks post-surgery. Induction of immunosuppression consisted of a humanized monoclonal antibody (Basiliximab) and corticosteroids. Postoperative maintenance immunosuppression regimens comprised a dual tacrolimus-based drug regimen that included prednisolone. Oral tacrolimus was administered to maintain a trough level of 10-15 ng/mL for the first 4 weeks, 5-10 ng/mL for the next 2 months, and 5 ng/mL, thereafter. Intravenous methylprednisolone (10 mg/kg) was given intraoperatively and tapered to 0.5 mg/kg on day 7. Beginning on day 8, patients were switched to oral prednisolone, starting at 0.5 mg/kg/d and tapered down during the next 2-3 months.
Cytomegalovirus prophylaxis with intravenous (IV) ganciclovir (5 mg/kg twice daily) was started on postoperative day 3, for a period of 14 days. Therapy was then switched to oral valganciclovir (17 mg/kg once daily) for at least 3 months following surgery. Seronegative recipients who had received an allograft from a CMV-seropositive donor were given oral valganciclovir for 6 months post-surgery. All patients also received sulfamethoxazole-trimethoprim as a pneumocystis jirovecii prophylaxis, 3 days/wk for 12 months post-surgery.
dye. qRT-PCR was performed under the following conditions: 50ºC for 2 minutes, 95ºC for 10 minutes followed by 50 cycles of 95ºC for 15 seconds, and 60ºC for 1 minute. Detection of RnaseP was used to evaluate the quality of the NA. Reaction was carried out under similar conditions by primers and probes to identify HHV-6 variants A and B, as previously described by Boutolleau et al 14 The sensitivity (limit of detection) of our qRT-PCR method for HHV-6 was 10 copies/reaction, equivalent to 100 copies per 0.2 mL of the original sample (plasma, whole blood, or biopsy homogenate). Answers were given qualitatively.
A positive control of 100 copies of HHV-6 genomes was routinely included in each test and continuously monitored using the LeveyJennings chart to ensure test sensitivity and stability. In the event that
the Ct (cycle threshold) value of the positive control diverges above or below two standard deviations, the test was disqualified and repeated.
A semi-quantitative estimation of the copy number for each positive result can be deduced by comparing the Ct value of the specimen to that of the positive control. A difference of 3.3 Ct s represents roughly one log difference in the copy number. 
| Serology analysis

| Ethics
The study was approved by the Institutional Ethics Committee of the Rabin Medical Center, Israel.
| RE SULTS
During the study period, 26 pediatric LTs were performed at our center.
Mean age at transplantation was 5.61 years, median, 5.55, age range, 5 months-15.4 years. Nine transplanted children were aged 2 years or less; five were less than a year.
Laboratory evaluations to detect HHV-6 infection were performed in seven of these 26 children. Four cases of primary HHV-6 were identified (Table 1 ). All primary infections occurred in children who were transplanted below the age of 1 year. In three out of four patients, time 
| C A S E REP ORTS
| Patient 1
A female infant was transplanted at the age of 6 months due to biliary atresia from a living-related donor. While still hospitalized in our department, 23 days posttransplantation and after switching from IV ganciclovir to a once daily dosage of oral valganciclovir, fever, elevated liver enzymes, and elevated bilirubin, were noted.
Due to suspected cholangitis, she received vancomycin, ceftazidime, and metronidazole. Subsequently, no improvement was observed and primary HHV-6 infection was diagnosed. Therefore, the antiviral treatment was changed to IV ganciclovir resulting in a gradual improvement. A liver biopsy performed 28 days posttransplantation showed mild portal inflammation and mild acute cellular rejection. HHV-6 PCR was also found to be positive in the liver tissue. Pulse steroids were begun and a further gradual improvement ensued.
| Patient 2
A male infant was transplanted at the age of 8 months due to maple syrup urine disease from a deceased donor. After surgery, 
| Patient 3
A male infant was transplanted at the age of 8. He also suffered from a coinfection with cryptosporidium which was diagnosed 1 month later.
| Patient 4
A male infant was transplanted at the age of 6 months due to biliary atresia from a living-related donor. He presented to the emergency room 54 days posttransplantation with fever, pharyngitis, respiratory distress, diarrhea with mucoid stool, and vomiting. Antibiotic main epidemiological sources of infections in the transplanted child:
donor-derived, recipient-derived, nosocomial, and community. There are three potential transmission mechanisms: natural through oropharyngeal secretions, through blood products, or in a transplanted liver allograft. 9, 16, 17 In Yoshikawa et al's 9 study, five seronegative pediatric liver transplant recipients received livers from seropositive mothers and all suffered from a primary infection 2-3 weeks posttransplantation, which suggests that the infection originated from the graft. Other studies, have confirmed that HHV-6 is detected in hepatocytes and in peripheral blood mononuclear cells found in the liver and therefore is capable of causing a latent infection. 4, 18 These findings reinforce the hypothesis that the infection is donor-derived.
Community-acquired infections cannot serve as an explanation for
infection in all our children, since two children were still hospitalized in isolated rooms when the infection was acquired. Yet, a nosocomial infection from an adult caregiver could not be ruled out and other sources of infection ,that is, blood infusions can be also the source of infection. 19 Clinical presentation of primary HHV-6 in immunocompetent children varies, 93% are symptomatic, when the most common symptoms are fussiness, rhinorrhea, and fever. 3 All of our patients had unexplained fever and elevated levels of liver enzymes.
Interestingly, the typical rash associated with roseola infantum did not appear in any of our patients. This rash is rarely seen in immunocompromised patients, supporting the view that the host immunity plays an important role in the pathogenesis of skin eruption.
9,11
Other indications for primary HHV-6 infection were pharyngitis and diarrhea. As described elsewhere, diarrhea and fever were the most common symptoms in immunocompromised patients while only 26% of immunocompetent children with primary HHV-6 infection had diarrhea. 3, 11 These findings should alert physicians of the possibility of primary HHV-6 infection and prompt investigation should be implemented.
All the children in our study suffered from HHV-6 type B, in line with previously published data demonstrating that the most common strain isolated from healthy symptomatic children as well as liver transplant recipients, was HHV6-B. 4, 8, [20] [21] [22] Human herpes virus 6 infection is known to cause liver dysfunction presumed by increasing lymphocytes in the liver, infecting hepatocytes, releasing cytokines which cause hepatic cell injury, and causing graft rejection. 2, 4, 8, 23, 24 Allograft infection by HHV-6 was associated with portal lymphocyte infiltration and an increase in expression of adhesion molecules on vascular endothelial cells which can lead to graft dysfunction or rejection. 4, 23 Yet, the correlation between rejection and post-transplant HHV-6 infection is still undetermined. On the one hand, reports in the literature correlate HHV-6 infection post-liver transplant with rejection 8, 24 and on the other hand, studies have found no correlation or a correlation only during the first 30 days posttransplantation. 11, 20, 25 It remains uncertain as to whether the infection mimics or triggers acute graft rejection.
10
In three out of four of our patients, a liver biopsy was performed due to suspected rejection, but only one biopsy showed inflammation and acute cellular rejection. HHV-6 PCR was positive in the biopsy proven rejection. The question of whether anti-rejection treatment should be given is still debatable.
Human herpes virus 6 has been shown to be associated with opportunistic infections and CMV disease which was attributed to the indirect effects of HHV-6 replication and its immunomodulatory properties. 2, 4, 18, 25, 26 Some studies did not observe this correlation and hypothesized that the low rate of CMV coinfection was due to the prophylactic treatment given to at risk patients. 8, 11 We did not detect a CMV coinfection in our study, however, one patient with EBV infection and sequential PTLD, was documented. Although uncommon, this coinfection has been previously described in liver transplanted patients. 11, 25 Coinfection with cryptosporidium was found in two out of the four infants. We did not find any reports of this specific coinfection. The association between these two pathogens should be further investigated. It has been proposed that the HHV-6 infection itself does not predispose to other infections but serves as a marker for profound immunosuppression. There is no consensus as to the effects of universal prophylaxis mainly given to prevent CMV (especially ganciclovir-containing regimens) on HHV-6. Some studies have reported effects of ganciclovir on HHV-6 4,16,26 while others found no effect. 4, 6, 16, 26 Ylinen et al 11 revealed that primary HHV-6 infection was less common among patients who received valganciclovir prophylaxis, although the frequency of HHV-6 infection was higher among these patients.
Although studies performed in adults did not support routine monitoring, Ylinen et al found that routine HHV-6 posttransplantation avoided unnecessary biopsies and medications. 11, 26, 27 One should bear in mind that our described children are heavily immunosuppressed and hence, a breakthrough infection while on prophylactic treatment may occur.
Our study has several limitations; it is retrospective and the number of patients is small. However, a primary infection in this specific group of children has been rarely described. Testing for HHV-6 was not routinely performed, thus, asymptomatic patients could not be identified.
The current study focused on a pediatric primary infection with 
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